NCT02699333 is a clinical trial in Colitis, Microscopic, sponsored by University of North Carolina, Chapel Hill.

Who is sponsoring NCT02699333?

NCT02699333 is sponsored by University of North Carolina, Chapel Hill.

What condition does NCT02699333 study?

NCT02699333 studies Colitis, Microscopic.

Is NCT02699333 still recruiting?

NCT02699333 is currently completed. Last updated 21 February 2021.

Last reviewed 2021-02-21 · How we verify

NCT02699333

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Risk Factors for Microscopic Colitis

Completed Last updated 21 February 2021

What this trial tests

trial in Colitis, Microscopic in 346 participants. Completed in 24 December 2020.

Timeline

1 May 2016

Primary endpoint
24 December 2020

24 December 2020

Quick facts

Lead sponsor	University of North Carolina, Chapel Hill
Status	Completed
Study type	OBSERVATIONAL
Enrollment	346
Start date	1 May 2016
Primary completion	24 December 2020
Estimated completion	24 December 2020
Sites	1 location across United States

Conditions studied

Colitis, Microscopic — all drugs for Colitis, Microscopic →

Sponsor

University of North Carolina, Chapel Hill

Who can join

35 and older, any sex, with Colitis, Microscopic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Microscopic colitis is a common cause of watery diarrhea, particularly in the elderly. Although the incidence is comparable to ulcerative colitis and Crohn's disease, the etiology is unknown. Understanding the etiology of microscopic colitis is an important step in developing logical interventions to decrease the burden from microscopic colitis. This research could provide critical insights into the etiology of this poorly studied condition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of North Carolina, Chapel Hill trials

Trials by the same sponsor.

NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02699333 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
Last refreshed: 21 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02699333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing